ATE198334T1 - 1,2,4-triazolo(1,5-c)pyrimidin-heterocyclische analoge mit antagonistischer aktivität auf dem adenosine a2a rezeptor - Google Patents

1,2,4-triazolo(1,5-c)pyrimidin-heterocyclische analoge mit antagonistischer aktivität auf dem adenosine a2a rezeptor

Info

Publication number
ATE198334T1
ATE198334T1 AT96924840T AT96924840T ATE198334T1 AT E198334 T1 ATE198334 T1 AT E198334T1 AT 96924840 T AT96924840 T AT 96924840T AT 96924840 T AT96924840 T AT 96924840T AT E198334 T1 ATE198334 T1 AT E198334T1
Authority
AT
Austria
Prior art keywords
pct
adenosine
receptor
triazolo
antagonistic activity
Prior art date
Application number
AT96924840T
Other languages
English (en)
Inventor
Pier Giovanni Baraldi
Barbara Cacciari
Monica Viziano
Silvio Dionisotti
Ennio Ongini
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ATE198334T1 publication Critical patent/ATE198334T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT96924840T 1995-07-28 1996-07-02 1,2,4-triazolo(1,5-c)pyrimidin-heterocyclische analoge mit antagonistischer aktivität auf dem adenosine a2a rezeptor ATE198334T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT95MI001671A IT1277392B1 (it) 1995-07-28 1995-07-28 Analoghi eterociclici di 1,2,4-triazolo(1,5-c]pirimidine ad attivita' antagonista per il recettore a2a dell'adenosina
PCT/EP1996/002881 WO1997005138A1 (en) 1995-07-28 1996-07-02 1,2,4-TRIAZOLO[1,5-c]PYRIMIDINE HETEROCYCLIC ANALOGUES HAVING ANTAGONISTIC ACTIVITY ON ADENOSINE A2a RECEPTOR

Publications (1)

Publication Number Publication Date
ATE198334T1 true ATE198334T1 (de) 2001-01-15

Family

ID=11372092

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96924840T ATE198334T1 (de) 1995-07-28 1996-07-02 1,2,4-triazolo(1,5-c)pyrimidin-heterocyclische analoge mit antagonistischer aktivität auf dem adenosine a2a rezeptor

Country Status (11)

Country Link
US (1) US5935964A (de)
EP (1) EP0856003B1 (de)
AT (1) ATE198334T1 (de)
CA (1) CA2227991C (de)
DE (1) DE69611377T2 (de)
DK (1) DK0856003T3 (de)
ES (1) ES2153118T3 (de)
GR (1) GR3035309T3 (de)
IT (1) IT1277392B1 (de)
PT (1) PT856003E (de)
WO (1) WO1997005138A1 (de)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4077155B2 (ja) * 1998-04-03 2008-04-16 株式会社大塚製薬工場 トリアゾロプリン誘導体、該誘導体を含有する医薬組成物、アデノシンａ３受容体親和剤および喘息治療剤
HUP0103836A3 (en) * 1998-06-02 2003-05-28 Osi Pharmaceuticals Inc Uniond Pyrrolo[2,3d]pyrimidine compositions and their use
US6878716B1 (en) 1998-06-02 2005-04-12 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A1 receptor and uses thereof
US6686366B1 (en) 1998-06-02 2004-02-03 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A3 receptor and uses thereof
US6921825B2 (en) 1998-09-16 2005-07-26 King Pharmaceuticuals Research & Development, Inc. Adenosine A3 receptor modulators
US6448253B1 (en) * 1998-09-16 2002-09-10 King Pharmaceuticals Research And Development, Inc. Adenosine A3 receptor modulators
US6686343B1 (en) * 1999-09-28 2004-02-03 Otsuka Pharmaceutical Factory, Inc. Triazolopurine derivatives, pharmaceutical compositions containing the derivatives, and adenosine A3 receptor affinitive agents
US7160890B2 (en) 1999-12-02 2007-01-09 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A3 receptor and uses thereof
US6664252B2 (en) 1999-12-02 2003-12-16 Osi Pharmaceuticals, Inc. 4-aminopyrrolo[2,3-d]pyrimidine compounds specific to adenosine A2a receptor and uses thereof
KR100840727B1 (ko) 1999-12-02 2008-06-23 오에스아이 파마슈티컬스, 인코포레이티드 아데노신 ａ1, ａ2ａ 및 ａ3 수용체 특이 화합물 및 그의 사용방법
US6680322B2 (en) 1999-12-02 2004-01-20 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A1 receptors and uses thereof
NZ522326A (en) * 2000-05-26 2006-03-31 Schering Corp Adenosine A2A receptor antagonists
US6680324B2 (en) * 2000-12-01 2004-01-20 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A1 receptors and uses thereof
US6673802B2 (en) 2000-12-01 2004-01-06 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A3 receptor and uses thereof
GB0100624D0 (en) * 2001-01-10 2001-02-21 Vernalis Res Ltd Chemical compounds VII
WO2003022283A1 (en) * 2001-09-13 2003-03-20 Schering Corporation Combination of an adenosine a2a receptor antagonist and an antidepressant or anxiolytic
IL160878A0 (en) 2001-10-15 2004-08-31 Schering Corp Imidazo (4,3-e)-1,2,4-triazolo (1,5-c) pyrimidines as adenosine a2a receptor antagonists
MXPA04005209A (es) 2001-11-30 2004-08-19 Schering Corp Antagonistas del receptor de adenosina a2a.
DE60234118D1 (de) 2001-11-30 2009-12-03 Osi Pharm Inc Verbindungen, die für Adenosin A1 und A3 Rezeptoren spezifisch sind, und deren Anwendungen
PE20030739A1 (es) 2001-11-30 2003-08-28 Schering Corp Antagonistas del receptor de adenosina a2a
IL161573A0 (en) 2001-11-30 2004-09-27 Schering Corp [1,2,4]-TRIAZOLE BICYCLIC ADENOSINE A2a RECEPTOR ANTAGONISTS
ATE458483T1 (de) 2001-12-20 2010-03-15 Osi Pharm Inc Selektive pyrimidin-a2b-antagonistenverbindungen, ihre synthese und verwendung
US20030229067A1 (en) 2001-12-20 2003-12-11 Arlindo Castelhano Pyrrolopyrimidine A2b selective antagonist compounds, their synthesis and use
NZ528591A (en) * 2002-02-01 2006-11-30 King Pharmaceuticals Res & Dev 8-heteroaryl xanthine adenosine A2B receptor antagonists and their pharmaceutical use
MXPA04000908A (es) * 2002-05-30 2004-03-26 King Pharmaceuticals Res & Dev Compuestos farmaceuticamente activos que tienen estructura de anillo de pirazolotriazolopirimidina triciclica y metodos de uso.
US20060106040A1 (en) * 2002-12-19 2006-05-18 Michael Grzelak Adenosine A2a receptor antagonists for the treatment of extra-pyramidal syndrome and other movement disorders
TWI331036B (en) 2002-12-19 2010-10-01 Schering Corp Adenosine a2a receptor antagonists for the treatment of extra-pyramidal syndrome and other movement disorders
JP4527712B2 (ja) 2003-04-23 2010-08-18 シェーリング コーポレイション ２−アルキニル−ピラゾロ−［４，３−ｅ］−１，２，４−トリアゾロ−［１，５−ｃ］−ピリミジンアデノシンＡ２ａレセプターアンタゴニストおよび２−アルケニル−ピラゾロ−［４，３−ｅ］−１，２，４−トリアゾロ−［１，５−ｃ］−ピリミジンアデノシンＡ２ａレセプターアンタゴニスト
PE20060185A1 (es) 2004-04-21 2006-03-20 Schering Corp ANTAGONISTA DEL RECEPTOR A2A DE LA ADENOSINA CON ESTRUCTURA DE PIRAZOLO--[4,3-e]-1,2,4-TRIAZOLO-[1,5-c]-PIRIMIDINA
AR057817A1 (es) 2005-09-19 2007-12-19 Schering Corp Antagonistas del receptor a2a de 2-heteroaril-pirazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pirimidin adenosina. composiciones farmaceuticas
AR056080A1 (es) 2005-09-23 2007-09-19 Schering Corp 7-[2-[4-(6-fluoro-3-metil-1,2-benciosoxazol-5-il)-1-piperazinil]etil]-2-(1-propinil)-7h-pirazol-[4,3-e]-[1,2,4]-triazol-[1,5-c] -pirimidin-5-amine
ES2273599B1 (es) 2005-10-14 2008-06-01 Universidad De Barcelona Compuestos para el tratamiento de la fibrilacion auricular.
EP2023729B1 (de) 2006-06-06 2016-05-04 Intra-Cellular Therapies, Inc. Organische verbindungen
US7691869B2 (en) * 2007-03-30 2010-04-06 King Pharmaceuticals Research And Development, Inc. Pyrrolotriazolopyrimidine derivatives, pharmaceutical compositions containing them and methods of treating conditions and diseases mediated by the adenosine A2A receptor activity
KR20100094551A (ko) 2007-12-06 2010-08-26 인트라-셀룰라 써래피스, 인코퍼레이티드. 유기 화합물
CA2717172A1 (en) 2008-03-04 2009-09-11 Schering Corporation 1,2,4-triazolo[4,3-c]pyrimidin-3-one and pyrazolo [4,3-e] -1,2,4-triazolo [4,3-c] pyrimidin-3-one compounds for use as adenosine a2a receptor antagonists
AU2009322905A1 (en) 2008-12-06 2010-06-10 Intra-Cellular Therapies, Inc. Organic compounds
US8927556B2 (en) 2008-12-06 2015-01-06 Intra-Cellular Therapies, Inc. 1H-pyrrolo[3,4-D]pyrimidin-2(6H)-one compounds
JP5813511B2 (ja) 2008-12-06 2015-11-17 イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−Ｃｅｌｌｕｌａｒ Ｔｈｅｒａｐｉｅｓ， Ｉｎｃ． 有機化合物
WO2011101861A1 (en) 2010-01-29 2011-08-25 Msn Laboratories Limited Process for preparation of dpp-iv inhibitors
WO2011153136A1 (en) 2010-05-31 2011-12-08 Intra-Cellular Therapies, Inc. Organic compounds
EP2590657A4 (de) 2010-05-31 2014-02-12 Intra Cellular Therapies Inc Organische verbindungen
JP5843869B2 (ja) * 2010-09-24 2016-01-13 アドヴィナス・セラピューティックス・リミテッド アデノシン受容体拮抗薬としての縮合三環化合物
WO2014101120A1 (en) 2012-12-28 2014-07-03 Merck Sharp & Dohme Corp. Heterobicyclo-substituted-7-methoxy-[1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds with a2a antagonist properties
US9546175B2 (en) 2014-08-07 2017-01-17 Intra-Cellular Therapies, Inc. Organic compounds
MX381180B (es) 2014-11-18 2025-03-12 Merck Sharp & Dohme Compuestos aminopirazina con propiedades antagonistas a2a.
EP3253390B1 (de) 2015-02-06 2022-04-13 Merck Sharp & Dohme Corp. Aminochinazolinverbindungen als a2a-antagonisten
EP3307067B1 (de) 2015-06-11 2022-11-02 Merck Sharp & Dohme LLC Aminopyrazinverbindungen mit a2a-antagonistischen eigenschaften
WO2017008205A1 (en) 2015-07-10 2017-01-19 Merck Sharp & Dohme Corp. Substituted aminoquinazoline compounds as a2a antagonist
US11498923B2 (en) 2017-12-13 2022-11-15 Merck Sharp & Dohme Llc Substituted imidazo[1,2-c]quinazolines as A2A antagonists
DE102019116986A1 (de) 2019-06-24 2020-12-24 Helmholtz-Zentrum Dresden-Rossendorf E. V. Deuterierte 7-(3-(4-(2-([18F]Fluor)ethoxy)phenyl)propyl)-2-(furan-2-yl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amin-Derivate
CN111072676B (zh) * 2019-12-12 2021-07-16 广东东阳光药业有限公司 含氮稠合三环衍生物及其用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1264901B1 (it) * 1993-06-29 1996-10-17 Schering Plough S P A Analoghi eterociclici di 1,2,4-triazolo(15-c)pirimidine ad attivita' antagonista per il recettore a2 dell'adenosina
ES2165393T3 (es) * 1993-07-27 2002-03-16 Kyowa Hakko Kogyo Kk Remedio contra la enfermedad de parkinson.

Also Published As

Publication number Publication date
EP0856003B1 (de) 2000-12-27
GR3035309T3 (en) 2001-04-30
IT1277392B1 (it) 1997-11-10
ES2153118T3 (es) 2001-02-16
DE69611377T2 (de) 2001-04-26
DK0856003T3 (da) 2001-01-22
WO1997005138A1 (en) 1997-02-13
DE69611377D1 (de) 2001-02-01
CA2227991A1 (en) 1997-02-13
US5935964A (en) 1999-08-10
ITMI951671A1 (it) 1997-01-28
CA2227991C (en) 2001-09-11
EP0856003A1 (de) 1998-08-05
PT856003E (pt) 2001-04-30
ITMI951671A0 (it) 1995-07-28

Similar Documents

Publication Publication Date Title
ATE198334T1 (de) 1,2,4-triazolo(1,5-c)pyrimidin-heterocyclische analoge mit antagonistischer aktivität auf dem adenosine a2a rezeptor
DE69622031D1 (de) INDOLDERIVATE ALS cGMP-PDE INHIBITOREN
GR3034415T3 (en) Pyrazole derivatives and processes for the preparation thereof
DE69329727D1 (de) Neue imidazol derivate, ihre herstellung und therapeutische verwendung
HUP9901820A2 (hu) 4-Amino-pirimidin-származékok, ezeket tartalmazó gyógyszerkészítmények, alkalmazásuk és eljárás előállításukra
ITMI931396A0 (it) Analoghi eterociclici di 1,2,4-triazolo[15-c]pirimidine ad attivita' antagonista per il recettore a2 dell'adenosina
NZ331874A (en) Arylamino fused pyridines and pyrimidines and their use in treating psychiatric and neurological diseases
PH31614A (en) 1-Substituted, 2-substituted 1H-imidazo Ä4,5-cÜquinolin-4-amines.
BG101198A (en) Use of 2-[(dihydro)pyrazolyl-3'-oxymethylene]-anilides as pest-control agents and fungicides
DE69711241D1 (de) 3-aryl pyrazolo[4,3-d]pyrimidin derivaten; corticotropin auslösefaktor- (crf1) spezifischen liganden
DK0779887T3 (da) Hidtil ukendte benzimidazolderivater med CGMP-phosphodiesteraseinhiberende aktivitet
ES2134929T3 (es) Derivados de pirrolo-piridina como ligandos para receptores de dopamina.
ES2120025T3 (es) Derivados de xantina utilizados como antagonistas de receptores de adenosina a1.
ATE102626T1 (de) Heterocyclische verbindungen, ihre darstellung und verwendung.
CA2244621A1 (en) 4-aminopyrrole (3,2-d) pyrimidines as neuropeptide y receptor antagonists
ES2143224T3 (es) Derivados naftamida de 3-beta-amino azabiciclo octano o nonano, como agentes antipsicoticos.
ATE65503T1 (de) Indolo-pyrazino-benzodiazepin-derivate.
MX9707187A (es) Derivados de imidazopiridina.
EP0462468A3 (en) 9-amino-2-phenylbicyclo(3.3.1)nonane and 9-amino-2-phenylbicyclo(3.3.1)-non-2-ene and therapeutic agents containing them
DE59809929D1 (de) 6-substituierte 1,2,4a,5a,8a,8b-hexahydro- und 1,2,3,4,4a,5a,8a,8b-oktahydro-6h-pyrrolo[3',4':4,5]furo[3,2-b]pyrid-8(7h)-on derivate und ihre verwendung zur bekämpfung von endoparasiten
SU1786802A1 (ru) 2,4-ДИМЕТИЛ-9-ОКСИПИРИДО[1,2-a]ПИРИМИДИНИЙХЛОРИД, ОБЛАДАЮЩИЙ АНТИДЕПРЕССИВНОЙ АКТИВНОСТЬЮ
MX9700125A (es) Compuestos de pirimidina.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee